Androgens and prostate cancer: Biology, pathology and hormonal therapy
- 1 April 1997
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (4) , 545-554
- https://doi.org/10.1016/s0959-8049(96)00444-3
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- The human androgen receptor: Domain structure, genomic organization and regulation of expressionPublished by Elsevier ,2003
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 inductionEndocrinology, 1995
- Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I TrialJNCI Journal of the National Cancer Institute, 1993
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- The Use of Ketoconazole as an Inhibitor of Steroid ProductionNew England Journal of Medicine, 1987
- Growth Factors in the ProstateArchives of Andrology, 1987
- Metabolic action of prolactin in regressing prostate: Independent of androgen actionThe Prostate, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984